$EL

BARSHEFSKY CHARLENE sold $373K of EL (indirect holdings)

BARSHEFSKY CHARLENE sold 3,775 indirectly-held shares of ESTEE LAUDER COMPANIES INC (EL) at $98.82 ($0.37M total) on 2026-09-09.

Original reporting
SEC EDGAR · BARSHEFSKY CHARLENE
Published Sep 10, 2026, 8:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EL
Neutral
medium confidence
Mentioned
$EL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ELNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to affect EL's price materially.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

The sale is part of a larger indirect holding; overall insider ownership remains substantial.

Relevance 4/10Novelty 4/10Timing: Filed after market close on 2026-09-09

Background

SEC Form 4 filings disclose insider transactions; traders monitor them for signals.

Company-level read

Ticker impact

$ELNeutralMedium confidence
Context

Director Charene Barshefsky sold 3,775 shares of Estée Lauder (EL) for $373,045, reducing her stake to 50,971 shares.

Expected impact

Minor downward pressure, likely within normal trading noise.

Evidence & confidence

Insider sales under $1M by a director are routine and rarely move the stock significantly.

Market effects

No broader sector impact; typical insider transaction.

Limited to U.S. investors tracking Estée Lauder.

Minimal global relevance.

Counterpoint

If the director anticipates near-term weakness, the sale could hint at downside risk.

Key entities

  • Estée Lauder Companies Inc

    US-listed cosmetics and beauty products company (ticker EL).

  • Charene Barshefsky

    Director of Estée Lauder.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ELMed

Why is Estee Lauder stock climbing today?

Estee Lauder (EL) stock rose 2.6% in pre-market trading after Barclays upgraded it to Overweight and raised its price target to $108, citing broad recovery and strong Q4 2026 results. The company reported adjusted EPS of $0.39 and revenue of $3.63B, both beating estimates. Barclays highlighted balanced revenue growth and margin expansion potential. Bernstein SocGen maintained a Market Perform rating with a $106 target. The broader market traded modestly lower.

$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.